Nilmadhab Roy | Medicine | Young Scientist Award

Published on by Academic Achievements

Mr. Nilmadhab Roy | Medicine | Young Scientist Award 

Mr. Nilmadhab Roy | Medicine | Ph. D. Scholar at Vellore Institute of Technology | India

Mr. Nilmadhab Roy is a dedicated chemical sciences researcher recognized for his growing contributions to coordination chemistry, metallodrug design, and advanced photodynamic therapeutic systems. He holds solid academic training in chemistry, supported by postgraduate qualifications and advanced research coursework that strengthened his foundation in inorganic chemistry, medicinal chemistry, and organometallic synthesis. Throughout his professional experience, Mr. Nilmadhab Roy has been associated with reputed research laboratories where he gained hands-on expertise in designing metal-based complexes, fluorescence imaging tools, ligand engineering, and mechanistic exploration of anticancer agents. His research interests include the synthesis of ruthenium, iridium, and rhenium complexes, development of luminescent biomolecular probes, theranostic platforms, mitochondrial-targeting agents, and redox-modulating metallotherapeutics for cancer treatment. He possesses strong research skills in experimental inorganic chemistry, spectroscopy, cell-based assays, molecular docking, imaging analysis, and structure–activity relationship evaluation. His collaborative projects often involve multidisciplinary teams focusing on targeted drug delivery, cancer theranostics, organelle-specific therapy, and mechanistic biochemical interactions. Mr. Nilmadhab Roy has co-authored several high-impact publications in internationally indexed journals, including Coordination Chemistry Reviews, Inorganica Chimica Acta, Polyhedron, Dalton Transactions, and ACS Omega, demonstrating his strong scientific judgment and experimental rigor. His work has earned increasing citations and recognition from researchers worldwide, reflecting his contribution to the advancement of next-generation metallopharmaceuticals. He has also participated in academic conferences, research workshops, and institutional scientific programs that enhanced his leadership, teamwork, and knowledge-dissemination skills. Mr. Nilmadhab Roy continues to explore innovative routes in organelle-specific targeting, luminescent metal complexes, and anticancer mechanisms, aiming to contribute to the evolution of safe, effective, and sustainable therapeutic materials. His academic discipline, research productivity, and commitment to scientific advancement position him as a promising young researcher with substantial potential for future innovations in inorganic medicinal chemistry.

Profile: Google Scholar

Featured Publications

  1. Kar, B., Das, U., Roy, N., & Paira, P. (2023). Recent advances on organelle specific Ru(II)/Ir(III)/Re(I) based complexes for photodynamic therapy. 92 citations.

  2. Sharma, A., Sudhindra, P., Roy, N., & Paira, P. (2020). Advances in novel iridium (III) based complexes for anticancer applications: A review. 77 citations.

  3. Pete, S., Roy, N., Kar, B., & Paira, P. (2022). Construction of homo and heteronuclear Ru(II), Ir(III) and Re(I) complexes for target specific cancer therapy. 46 citations.

  4. Sudhindra, P., Sharma, S. A., Roy, N., Moharana, P., & Paira, P. (2020). Recent advances in cytotoxicity, cellular uptake and mechanism of action of ruthenium metallodrugs: A review. 44 citations.

  5. Kar, B., Roy, N., Pete, S., Moharana, P., & Paira, P. (2020). Ruthenium and iridium based mononuclear and multinuclear complexes: A breakthrough of next-generation anticancer metallopharmaceuticals. 43 citations.

  6. Sarkar, B., Mondal, A., Madaan, Y., Roy, N., Moorthy, A., Kuo, Y. C., & Paira, P. (2019). Luminescent anticancer ruthenium (II)-p-cymene complexes of extended imidazophenanthroline ligands: Synthesis, structure, reactivity, biomolecular interactions and live cell studies. 43 citations.

  7. Mondal, A., Sen, U., Roy, N., Muthukumar, V., Sahoo, S. K., & Bose, B., et al. (2021). DNA targeting half sandwich Ru(II)-p-cymene-N^N complexes as cancer cell imaging and terminating agents: Influence of regioisomers in cytotoxicity. 41 citations.

 

Athina Tsili | Medicine | Best Researcher Award

Published on by Academic Achievements

Assoc. Prof. Dr. Athina Tsili | Medicine | Best Researcher Award

Assoc. Prof. Dr. Athina Tsili | Medicine | Associate Professor at University of Ioannina | Greece

Assoc. Prof. Dr. Athina Tsili is a distinguished medical academic and radiologist currently serving as an Associate Professor in the Department of Clinical Radiology at the School of Health Sciences, Faculty of Medicine, University of Ioannina, Greece. She obtained her medical degree from the Aristotle University of Thessaloniki, School of Medicine, and completed her training in Radiology at the University Hospital of Ioannina. Dr. Tsili further pursued her Ph.D. at the same institution, focusing on advanced radiologic imaging and diagnostic methodologies. Her professional experience spans over two decades, including service as a Consultant Radiologist and later as a lecturer and professor, reflecting her dedication to medical education and clinical excellence. Dr. Athina Tsili’s primary research interests lie in Genitourinary and Scrotal Imaging, with a focus on the use of MRI and ultrasound in diagnosing and staging testicular and urogenital pathologies. Her research has significantly contributed to international guidelines and radiologic protocols, especially through her active involvement with the European Society of Urogenital Radiology (ESUR), where she currently serves as Secretary-Treasurer. Her expertise extends to clinical imaging standardization, multidisciplinary collaboration in radiologic evaluation, and the integration of imaging data into precision medicine. With an impressive record of 96 Scopus-indexed publications, an H-index of 26, and over 1800 citations, Dr. Tsili has established herself as a leading voice in European radiologic research. Her accolades include recognition from leading academic and clinical societies for her contributions to diagnostic imaging and radiologic education. Known for her precision, leadership, and collaborative research initiatives, Assoc. Prof. Dr. Athina Tsili continues to mentor young radiologists and contribute to international imaging standards, advancing the future of diagnostic radiology through innovation, evidence-based practice, and academic excellence.

Profile: Google Scholar

Featured Publications

Tsili, A. C., Richenberg, J., Belfield, J., Ramchandani, P., Rocher, L., Freeman, S., … (2015). Testicular microlithiasis imaging and follow-up: guidelines of the ESUR scrotal imaging subcommittee. European Radiology, 25(2), 323–330. Cited by 168.

Tsili, A. C., Tsampoulas, C., Giannakopoulos, X., Stefanou, D., Alamanos, Y., … (2007). MRI in the histologic characterization of testicular neoplasms. American Journal of Roentgenology, 189(6), W331–W337. Cited by 127.

Tsili, A. C., Argyropoulou, M. I., Giannakis, D., Sofikitis, N., Tsampoulas, K. (2010). MRI in the characterization and local staging of testicular neoplasms. American Journal of Roentgenology, 194(3), 682–689. Cited by 113.

Freeman, S., Bertolotto, M., Richenberg, J., Belfield, J., Dogra, V., Huang, D. Y., … Tsili, A. C. (2020). Ultrasound evaluation of varicoceles: guidelines and recommendations of the ESUR Scrotal and Penile Imaging Working Group. European Radiology, 30(1), 11–25. Cited by 106.

Rocher, L., Ramchandani, P., Belfield, J., Bertolotto, M., Derchi, L. E., Correas, J. M., … Tsili, A. C. (2016). Incidentally detected non-palpable testicular tumours in adults at scrotal ultrasound: radiologic review and recommendations. European Radiology, 26(7), 2268–2278. Cited by 99.

Tsili, A. C., Bertolotto, M., Turgut, A. T., Dogra, V., Freeman, S., Rocher, L., … (2018). MRI of the scrotum: Recommendations of the ESUR Scrotal and Penile Imaging Working Group. European Radiology, 28(1), 31–43. Cited by 98.

Tsili, A. C., Efremidis, S. C., Kalef-Ezra, J., Giannakis, D., Alamanos, Y., Sofikitis, N., … (2007). Multi-detector row CT urography on a 16-row CT scanner in the evaluation of urothelial tumors. European Radiology, 17(4), 1046–1054. Cited by 86.

YU LI | Medicine | Best Researcher Award

Published on by Academic Achievements

Ms. YU LI | Medicine | Best Researcher Award

Ms. YU LI | Medicine – Postgraduate student at Huazhong University of Science and Technology, China

Li Yu is an emerging researcher in the medical field with a strong academic background and practical experience in clinical practice and medical research. Currently working as a resident in training at a prominent hospital in Wuhan, Li Yu is also pursuing a master’s degree at a well-regarded university in the same city. With a keen interest in predictive modeling, clinical analysis, and health data science, Li Yu has demonstrated significant promise in the academic and clinical sectors. Their research contributions aim to improve patient care and hospital management, especially in the areas of mortality risk prediction and understanding apoptosis mechanisms. Through a combination of academic research and clinical work, Li Yu strives to contribute to both theoretical knowledge and practical advancements in the medical field.

Profile:

Orcid

Education:

Li Yu’s educational journey reflects a strong commitment to medical sciences. They completed a Bachelor’s degree in Medicine from Jianghan University, where they laid the foundation for a deeper understanding of healthcare. Following that, Li Yu enrolled in the master’s program at the same university to further specialize in medical research and clinical practice. This advanced education has allowed them to combine practical skills with research expertise, equipping them to tackle complex medical problems. In parallel to formal education, Li Yu has also taken on teaching assistant responsibilities, enhancing their understanding of medical topics and contributing to the academic development of other students.

Experience:

Li Yu’s career trajectory has been marked by a blend of practical experience in clinical environments and academic involvement. Since 2022, Li Yu has been a resident in training in the General Practice Department at the Central Hospital of Wuhan, where they gained hands-on experience in patient care, diagnostics, and treatment. This role has allowed Li Yu to apply their theoretical knowledge in real-world settings, gaining valuable insights into patient outcomes and healthcare management. Additionally, Li Yu has contributed as a teaching assistant at Jianghan University, where they assist in guiding medical students through various courses in the medical sciences. This combination of clinical and academic roles showcases Li Yu’s dedication to both patient care and knowledge dissemination in the medical field.

Research Interests:

Li Yu’s research interests lie at the intersection of clinical medicine and data science, with a focus on improving healthcare outcomes through predictive analytics and the study of cellular processes. One key area of interest is apoptosis and its signaling pathways, as understanding these processes could lead to breakthroughs in treating diseases such as cancer and neurodegenerative conditions. Another significant focus is predictive modeling for patient outcomes, particularly in emergency medicine, such as predicting the risk of mortality in patients who have suffered from sudden cardiac arrest. By combining data analysis with clinical insight, Li Yu aims to create models that can aid healthcare professionals in making better decisions and improving patient survival rates. Through their research, Li Yu seeks to bridge the gap between theoretical knowledge and its practical application in medical practice.

Awards:

While Li Yu is early in their research career, their contributions to the medical field have already gained recognition. Their ongoing research projects on predictive modeling and apoptosis have placed them in contention for various awards in the research community. Although Li Yu has not yet received major formal awards, their work demonstrates the potential for significant future contributions to healthcare research. Given their academic achievements and research accomplishments, Li Yu is a strong candidate for future awards as they continue to build a body of impactful work in the field of medicine.

Publications:

Li Yu has contributed to several notable research articles published in reputable medical journals, reflecting their active participation in advancing medical knowledge. Some of their key publications include:

  1. “A Visual Analysis of Global Research Trends in Signaling Pathways and Key Molecules within Pan-Apoptosis Studies” (Published 2024 in Journal of Cellular Biology). This article provides an in-depth analysis of global trends in apoptosis research, shedding light on emerging pathways and key molecules involved in the process. 🌍🔬
  2. “Establishing and Validating a Predictive Model for the Risk of In-Hospital Mortality After the Return of Spontaneous Circulation in Patients with Sudden Death” (Published 2024 in Journal of Emergency Medicine). This research focuses on creating a risk model for predicting in-hospital mortality, an important advancement in the field of emergency medical care. ⚠️🩺
  3. “构建并验证猝死患者复苏成功后院内死亡的风险预测模型——一项病例对照研究” (Published 2024 in Chinese Journal of Medicine). This study examines risk prediction models for patients who survive the initial stages of sudden cardiac arrest, providing critical insights into patient care post-resuscitation. 🫀📊

Conclusion:

Li Yu is a promising researcher who is making significant strides in both academic and clinical settings. Their research interests in predictive modeling and apoptosis, combined with hands-on clinical experience, position them as a potential leader in the field of medical research. Though still early in their career, Li Yu’s dedication to improving patient care and advancing scientific knowledge has already led to noteworthy publications and academic contributions. As their research continues to evolve, it is likely that they will have an even greater impact on the medical community, making them a deserving candidate for future awards and recognition in the research field.